<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Niogret, Charlène</dc:creator>
  <dc:creator>Miah, S. M. Shahjahan</dc:creator>
  <dc:creator>Rota, Giorgia</dc:creator>
  <dc:creator>Fonta, Nicolas P.</dc:creator>
  <dc:creator>Wang, Haiping</dc:creator>
  <dc:creator>Held, Werner</dc:creator>
  <dc:creator>Birchmeier, Walter</dc:creator>
  <dc:creator>Sexl, Veronica</dc:creator>
  <dc:creator>Yang, Wentian</dc:creator>
  <dc:creator>Vivier, Eric</dc:creator>
  <dc:creator>Ho, Ping-Chih</dc:creator>
  <dc:creator>Brossay, Laurent</dc:creator>
  <dc:creator>Guarda, Greta</dc:creator>
  <dc:date>2019-03-29</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">The phosphatase Shp-2 was implicated in NK cell development and functions due to its  interaction with NK inhibitory receptors, but its exact role in NK cells is still unclear. Here we  show, using mice conditionally deficient for Shp-2 in the NK lineage, that NK cell development  and responsiveness are largely unaffected. Instead, we find that Shp-2 serves mainly to  enforce NK cell responses to activation by IL-15 and IL-2. Shp-2-deficient NK cells have  reduced proliferation and survival when treated with high dose IL-15 or IL-2. Mechanistically,  Shp-2 deficiency hampers acute IL-15 stimulation-induced raise in glycolytic and respiration  rates, and causes a dramatic defect in ERK activation. Moreover, inhibition of the ERK and  mTOR cascades largely phenocopies the defect observed in the absence of Shp-2. Together,  our data reveal a critical function of Shp-2 as a molecular nexus bridging acute IL-15 signaling  with downstream metabolic burst and NK cell expansion.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://susi.usi.ch/global/documents/318906</dc:identifier>
  <dc:identifier>https://localhost:5000/ark:/12658/srd1318906</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/318906/files/Niogret_NatCommun_2019.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1038/s41467-019-09431-3</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1318906</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>CC BY</dc:rights>
  <dc:source>Nature communications. - 2019, vol. 10, p. 1444</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Interleukins</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">NK cells</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Signal transduction</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">TOR signalling</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/57/59</dc:subject>
  <dc:title xmlns:ns5="xml" ns5:lang="en">Shp-2 is critical for ERK and metabolic engagement downstream of IL-15 receptor in NK cells</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
